RT

Rakesh Tewari

Director Director DIN 06601348
DIN 06601348 First appointment Mar 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2017
Shareholding value Locked Premium profile

About Rakesh Tewari

Data last updated:

Rakesh Tewari has 9 years in corporate governance. Formerly with 1 company, such as Biogen Pharmachem Industries Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06601348
Primary Designation Director
First Appointment 08 Mar 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Biogen Pharmachem Industries Limited L51100GJ1995PLC026702
Director08 Mar 20171995Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biogen Pharmachem Industries Limited
Premium access

Shareholding and investment profile for Rakesh Tewari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Tewari

Rakesh Tewari has 9 years in corporate governance. Formerly with 1 company, such as Biogen Pharmachem Industries Limited. Engaged in General Business. Contributes to corporate operations.

Rakesh Tewari is associated with 0 companies as a director.

Rakesh Tewari has expertise in General Business.

Rakesh Tewari has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available